Pfizer (PFE) Gains from Investment Securities (2009 - 2026)
Pfizer (PFE) reported Gains from Investment Securities of -$22.0 million for Q1 2026, down 114.47% year-over-year from $152.0 million in Q1 2025, and down 100.44% on a QoQ basis from $5.0 billion in Q4 2025.
Pfizer (PFE) has 18 years of Gains from Investment Securities data on file, last reported at -$22.0 million in Q1 2026.
- Quarterly Gains from Investment Securities fell 114.47% year-over-year to -$22.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 billion (up 2366.67% YoY) and the FY2025 annual result came in at $4.7 billion, up 1556.54% from the prior year.
- Gains from Investment Securities slipped to -$22.0 million in Q1 2026 per PFE's latest filing, from $5.0 billion in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $5.0 billion in Q4 2025 and bottomed at -$2.3 billion in Q4 2023.
- The 5-year median for Gains from Investment Securities is $13.0 million (2024), against an average of $282.7 million.
- The widest annual swing landed in 2022, when Gains from Investment Securities plunged 400.0%; it then soared 1195.0% in 2023.
- Tracing PFE's Gains from Investment Securities over 5 years: stood at $200.0 million in 2022, then plunged by 1246.5% to -$2.3 billion in 2023, then jumped by 100.57% to $13.0 million in 2024, then soared by 38284.62% to $5.0 billion in 2025, then plunged by 100.44% to -$22.0 million in 2026.
- Per Business Quant, the three latest PFE Gains from Investment Securities figures stand at -$22.0 million (Q1 2026), $5.0 billion (Q4 2025), and -$14.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -22.00 Mn |
| Mar 29, 2026 | -22.00 Mn |
| Dec 31, 2025 | 4.99 Bn |
| Dec 31, 2025 | 4.99 Bn |
| Sep 28, 2025 | -14.00 Mn |
| Sep 28, 2025 | -14.00 Mn |
| Jun 29, 2025 | -440.00 Mn |
| Jun 29, 2025 | -440.00 Mn |
| Mar 30, 2025 | 152.00 Mn |
| Mar 30, 2025 | 152.00 Mn |
| Sep 29, 2024 | 13.00 Mn |
| Sep 29, 2024 | 13.00 Mn |
| Jun 30, 2024 | -166.00 Mn |
| Jun 30, 2024 | -166.00 Mn |
| Mar 31, 2024 | 184.00 Mn |
| Mar 31, 2024 | 184.00 Mn |
| Dec 31, 2023 | -2.29 Bn |
| Dec 31, 2023 | -2.29 Bn |
| Oct 1, 2023 | 2.59 Bn |
| Oct 1, 2023 | 2.59 Bn |
| Jul 2, 2023 | 299.00 Mn |
| Jul 2, 2023 | 299.00 Mn |
| Apr 2, 2023 | 18.00 Mn |
| Apr 2, 2023 | 18.00 Mn |
| Oct 2, 2022 | 200.00 Mn |
| Oct 2, 2022 | 200.00 Mn |
| Jul 3, 2022 | -455.00 Mn |
| Jul 3, 2022 | -455.00 Mn |
| Apr 3, 2022 | -815.00 Mn |
| Apr 3, 2022 | -815.00 Mn |
| Oct 3, 2021 | 2.94 Bn |
| Oct 3, 2021 | 2.94 Bn |
| Jul 4, 2021 | 2.35 Bn |
| Jul 4, 2021 | 2.35 Bn |
| Apr 4, 2021 | -163.00 Mn |
| Apr 4, 2021 | -163.00 Mn |
| Dec 31, 2020 | 1.25 Bn |
| Dec 31, 2020 | 1.25 Bn |
| Sep 27, 2020 | 313.00 Mn |
| Sep 27, 2020 | 313.00 Mn |
| Jun 28, 2020 | -165.00 Mn |
| Jun 28, 2020 | -165.00 Mn |
| Mar 29, 2020 | 239.00 Mn |
| Mar 29, 2020 | 239.00 Mn |
| Dec 31, 2019 | 3.04 Bn |
| Dec 31, 2019 | 3.04 Bn |
| Sep 29, 2019 | 801.00 Mn |
| Sep 29, 2019 | 801.00 Mn |
| Jun 30, 2019 | -415.00 Mn |
| Jun 30, 2019 | -415.00 Mn |
| Mar 31, 2019 | 236.00 Mn |
| Mar 31, 2019 | 236.00 Mn |
| Dec 31, 2018 | 1.99 Bn |
| Dec 31, 2018 | 1.99 Bn |
| Sep 30, 2018 | 1.14 Bn |
| Sep 30, 2018 | 1.14 Bn |
| Jul 1, 2018 | 362.00 Mn |
| Jul 1, 2018 | 362.00 Mn |
| Apr 1, 2018 | 161.00 Mn |
| Apr 1, 2018 | 161.00 Mn |
| Dec 31, 2017 | -152.00 Mn |
| Dec 31, 2017 | -152.00 Mn |
| Oct 1, 2017 | -64.00 Mn |
| Oct 1, 2017 | -64.00 Mn |
| Jul 2, 2017 | -650.00 Mn |
| Jul 2, 2017 | -650.00 Mn |
| Apr 2, 2017 | 195.00 Mn |
| Apr 2, 2017 | 195.00 Mn |
| Dec 31, 2016 | -12.00 Mn |
| Dec 31, 2016 | -12.00 Mn |
| Oct 2, 2016 | 102.00 Mn |
| Oct 2, 2016 | 102.00 Mn |
| Jul 3, 2016 | -164.00 Mn |
| Jul 3, 2016 | -164.00 Mn |
| Apr 3, 2016 | -6.00 Mn |
| Apr 3, 2016 | -6.00 Mn |
| Dec 31, 2015 | -32.00 Mn |
| Dec 31, 2015 | -32.00 Mn |
| Sep 27, 2015 | 517.00 Mn |
| Sep 27, 2015 | 517.00 Mn |
| Jun 28, 2015 | -705.00 Mn |
| Jun 28, 2015 | -705.00 Mn |
| Mar 29, 2015 | 372.00 Mn |
| Mar 29, 2015 | 372.00 Mn |
| Dec 31, 2014 | 1.64 Bn |
| Dec 31, 2014 | 1.64 Bn |
| Sep 28, 2014 | 165.00 Mn |
| Sep 28, 2014 | 165.00 Mn |
| Jun 29, 2014 | 505.00 Mn |
| Jun 29, 2014 | 505.00 Mn |
| Mar 30, 2014 | -206.00 Mn |
| Mar 30, 2014 | -206.00 Mn |
| Dec 31, 2013 | 2.91 Bn |
| Dec 31, 2013 | 2.91 Bn |
| Jun 30, 2013 | -31.00 Mn |
| Jun 30, 2013 | -31.00 Mn |
| Mar 31, 2013 | 548.00 Mn |
| Mar 31, 2013 | 548.00 Mn |
| Dec 31, 2012 | 12.00 Mn |
| Dec 31, 2012 | 12.00 Mn |
| Apr 1, 2012 | 29.00 Mn |
| Apr 1, 2012 | 29.00 Mn |
| Dec 31, 2011 | 1.39 Bn |
| Dec 31, 2011 | 1.39 Bn |
| Oct 2, 2011 | 802.00 Mn |
| Oct 2, 2011 | 802.00 Mn |
| Jul 3, 2011 | 871.00 Mn |
| Jul 3, 2011 | 871.00 Mn |
| Apr 3, 2011 | -134.00 Mn |
| Apr 3, 2011 | -134.00 Mn |
| Dec 31, 2010 | 447.00 Mn |
| Dec 31, 2010 | 447.00 Mn |
| Oct 3, 2010 | -588.00 Mn |
| Oct 3, 2010 | -588.00 Mn |
| Jul 4, 2010 | -10.46 Bn |
| Jul 4, 2010 | -10.46 Bn |
| Apr 4, 2010 | 10.55 Bn |
| Apr 4, 2010 | 10.55 Bn |
| Dec 31, 2009 | -1.95 Bn |
| Dec 31, 2009 | -1.95 Bn |
| Sep 27, 2009 | 2.09 Bn |
| Sep 27, 2009 | 2.09 Bn |
| Jun 28, 2009 | -50.00 Mn |
| Jun 28, 2009 | -50.00 Mn |
| Mar 29, 2009 | -296.00 Mn |
| Mar 29, 2009 | -296.00 Mn |